Skip to main content
Clinical Trials/NL-OMON24115
NL-OMON24115
Recruiting
Not Applicable

Improving practicality of radiofrequency ablation for eradication of Barrett's mucosa: A randomized trial comparing two different treatment regimens for focal ablation using the HALO90 System.

AMC Amsterdam0 sites46 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Barrett's esophagus
Sponsor
AMC Amsterdam
Enrollment
46
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
AMC Amsterdam

Eligibility Criteria

Inclusion Criteria

  • 1\. Scheduled HALO90 ablation for BE (with or without neoplasia) after prior circumferential ablation using the HALO360 System for BE with flat low\-grade dysplasia (LGD) or high\-grade dysplasia (HGD) or for BE (with or without neoplasia) after prior endoscopic resection (ER) for lesions containing HGD or and early cancer;
  • 2\. One or more BE islands with a minimum size of 5\-mm;

Exclusion Criteria

  • 1\. Patients with endoscopically active inflammation in the treatment zone;
  • 2\. Esophageal stenosis preventing advancement of the endoscope with the HALO90 catheter.

Outcomes

Primary Outcomes

Not specified

Similar Trials